XML 32 R4.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
12 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Operating expenses    
General and administrative $ 6,846,599 $ 5,989,170
Research and development 22,260,349 13,344,421
Total operating expenses (29,106,948) (19,333,591)
Other income (expenses)    
Grant income 298,943 149,055
Research and development incentive income 2,465,691 1,830,186
Interest income, net 207,280 255,092
Gain on settlement of accounts payable 115,758
Financing related charges (151,133) (30,943)
Foreign exchange gain (loss), net (42,389) (49,789)
Total other income, net 2,894,150 2,153,601
Net loss before provision for income taxes (26,212,798) (17,179,990)
Income tax expense, current (82,181) (72,746)
Net loss and comprehensive loss $ (26,294,979) $ (17,252,736)
Net Loss per share Basic and diluted (in dollars per share) $ (0.54) $ (0.39)
Weighted average number of shares outstanding Basic and diluted (in shares) 48,906,470 44,655,725